These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32371813)

  • 1. Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?
    Liu D; Li YZ; Wu H
    J Hypertens; 2020 Jun; 38(6):1191-1192. PubMed ID: 32371813
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19.
    Curfman G
    JAMA; 2020 Jul; 324(2):177-178. PubMed ID: 32558905
    [No Abstract]   [Full Text] [Related]  

  • 3. Renin--angiotensin system blockers and the risk of critical or fatal coronavirus disease 2019 in African Americans.
    Thomopoulos C; Michalopoulou H
    J Hypertens; 2020 Dec; 38(12):2384-2386. PubMed ID: 33149061
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence That Renin-Angiotensin System Inhibitors Should Not Be Discontinued Due to the COVID-19 Pandemic.
    Carey RM; Wang JG
    Hypertension; 2020 Jul; 76(1):42-43. PubMed ID: 32436403
    [No Abstract]   [Full Text] [Related]  

  • 5. Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity.
    Otto CM
    Heart; 2020 Oct; 106(19):1451-1453. PubMed ID: 32928982
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?
    Henry RA
    CMAJ; 2020 Jun; 192(26):E728. PubMed ID: 32601254
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
    Patel AB; Verma A
    Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19.
    Williams B; Zhang Y
    Lancet; 2020 May; 395(10238):1671-1673. PubMed ID: 32416786
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality.
    Zhou F; Liu YM; Xie J; Li H; Lei F; Yang H; Qin JJ; Cai J; Zhang XJ; Wu B; Xia M; Xiang D; Yang C; Ma X; Xu Q; Lu Z; Lu H; Xia X; Wang D; Liao X; Peng G; Yang J; Huang X; Zhang BH; Yuan Y; Wei X; Liu PP; Wang Y; Zhang P; She ZG; Xia J; Li H
    Hypertension; 2020 Aug; 76(2):e15-e17. PubMed ID: 32493070
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019.
    Tedeschi S; Giannella M; Bartoletti M; Trapani F; Tadolini M; Borghi C; Viale P
    Clin Infect Dis; 2020 Jul; 71(15):899-901. PubMed ID: 32339215
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between angiotensin blockade and COVID-19 severity in Hong Kong.
    Cheung KS; Hung IFN; Leung WK
    CMAJ; 2020 Jun; 192(23):E635. PubMed ID: 32575056
    [No Abstract]   [Full Text] [Related]  

  • 14. Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome?
    Volpe M; Battistoni A
    Int J Cardiol; 2020 Dec; 321():150-154. PubMed ID: 32738257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
    Henry BM; Benoit S; Lippi G; Benoit J
    Prog Cardiovasc Dis; 2020; 63(5):702-703. PubMed ID: 32659343
    [No Abstract]   [Full Text] [Related]  

  • 16. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research.
    Omar MB
    Heart Lung; 2020; 49(4):351. PubMed ID: 32327200
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms by which angiotensin-receptor blockers increase ACE2 levels.
    Ferrario CM; Ahmad S; Groban L
    Nat Rev Cardiol; 2020 Jun; 17(6):378. PubMed ID: 32332868
    [No Abstract]   [Full Text] [Related]  

  • 18. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 19. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    Birnbaum RA
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427430
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
    Haug G; Eapen MS; Sohal SS
    N Engl J Med; 2020 Jun; 382(24):e92. PubMed ID: 32427429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.